In blood, this assay had insufficient sensitivity to detect TDP-43 in the majority of patients, yet also demonstrated elevated TDP-43 or pTDP-43 levels in FTD, AD and/or amyotrohic lateral sclerosis (ALS) patients with detectable plasma levels [113, 379, 383]. Here, TARDBP is linked to frontotemporal dementia.